Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

19.02 USD -0.03 (-0.16%)
Official Closing Price Updated: 5:20 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Alkermes Plc

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Alkermes Honors Black American Pioneers in Mental Health
Tags NASDAQ:ALKS Alkermes Workplace Inclusion
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2020 and Provides Financial Expectations for 2021
-- Revenues of $1.04 Billion in 2020, GAAP Loss per Share of $0.70 and Basic and Diluted Non-GAAP Earnings per Share of $0.43 -- 
From PR Newswire
Keeping Mental Health in Mind During a Pandemic Winter
Tags NASDAQ:ALKS Alkermes Exercise & Activity
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results
Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Thursday, Feb. 11, 2021 to discuss the company's fourth quarter and year-end 2020... 
From PR Newswire
Alcohol Use Disorder Treatment and Support Options
Tags Substance Abuse and Mental Health Services Administration (SAMHSA) Responsible Production & Consumption Disease Awareness
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Sr. Administrative Assistant Shares Her Motivation and Commitment
Tags Business Ethics Employee Engagement Cancer
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alcohol & Your Immune System
Tags Wellness Responsible Production & Consumption Good Health and Well/Being
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Sr. Director and Program Lead of Oncology Shares Her Motivation
Tags Disease Awareness Oncology Cancer
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Here's What Happens To Your Body After Just One Week Of Dry January
Tags Consumer Engagement Dry January Responsible Drinking
From 3BL Media: Corporate Social Responsibility, Energy and Health News
NIDA-Funded Study Evaluating Extended-Release Injectable Naltrexone Plus Bupropion for the Treatment of Methamphetamine Use Disorder Published in New England Journal of Medicine
Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension (XR-NTX) administered once every three... 
From PR Newswire
Alkermes to Present at the 39th Annual J.P. Morgan Healthcare Conference
Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 39th Annual J.P. Morgan Healthcare Conference. The... 
From PR Newswire
Alkermes Announces Updates to Executive Leadership Team
-- Blair C. Jackson Appointed Chief Operating Officer and Iain M. Brown Named Chief Financial Officer, Positioning Company for Continued Strong Execution of Business Strategy -- 
From PR Newswire
Thinking about buying stock in Immersion Corp, IRIDEX Corp, One Stop Systems, Phio Pharmaceuticals, or Alkermes?
InvestorsObserver issues critical PriceWatch Alerts for IMMR, IRIX, OSS, PHIO, and ALKS. 
From PR Newswire
FDA Accepts Alkermes' Resubmission of New Drug Application for ALKS 3831
- FDA Sets PDUFA Target Action Date of June 1, 2021 - 
From PR Newswire
Alkermes Shares Resources for Opioid Addiction
Tags Mobile Health Opioid Abuse and Addiction Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Resources for Those Managing Alcohol Use Disorder This Holiday Season
Tags Disease Awareness cdc Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Provides Tips for Managing Holiday Stress
Tags Health & Healthcare Improving Healthcare Access NASDAQ:ALKS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Announces Strategic Value Enhancement Plan and Continued Board Refreshment
- Commits to Non-GAAP Net Income Margin Targets of ~25% for FY 2023 and ~30% for FY 2024, Reflecting Rigorous Expense Management, Expected Revenue Growth and Commitment to Shareholder Value Creation - 
From PR Newswire
Alkermes Celebrates Giving Tuesday with Alkermes in Action Program
Tags Volunteering Alkermes NASDAQ:ALKS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review
-- No Clinical Efficacy or Safety Issues Raised and No Further Studies Required by FDA to Support Approval -- 
From PR Newswire
Alkermes Celebrates National Family Caregivers Month: Jessica's Story
Tags National Family Caregivers Month Employee Engagement Biopolar Disorder
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Recognizes the Value of Veterans
Tags Military Alkermes NASDAQ:ALKS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Lyra Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Lyra Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update 
From Business Wire News Releases
Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual Meeting
- Subcutaneous Dosing of ALKS 4230 in ARTISTRY-2 Showed Desired Immune Response and Safety Profile Consistent With the Observed Effects of Intravenous ALKS 4230 - 
From PR Newswire
Harris Poll Survey Offers Insights into Potential of Telepsychiatry During and After the COVID-19 Pandemic
Tags Social Impact & Volunteering Pharma News, Research & Solutions Good Health and Well/Being
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Resources for Those Recovering From or Struggling With Alcohol Use Disorder
Tags Good Health and Well/Being alcohol use disorder Alkermes
From 3BL Media: Corporate Social Responsibility, Energy and Health News
A Meaningful Difference for Cancer Patients and Loved Ones
Tags Alkermes Cancer Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Reschedules Third Quarter 2020 Financial Results Conference Call to 10:30 a.m. ET
Alkermes plc (Nasdaq: ALKS) announces that the conference call to discuss the company's third quarter financial results is rescheduled due to technical difficulties impacting the conference call... 
From PR Newswire
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
- Company Reports Third Quarter Revenues of $265.0 Million, GAAP Net Loss per Share of $0.00 and Basic and Diluted Non-GAAP Earnings per Share of $0.26 - 
From PR Newswire
Lyra Therapeutics Appoints Nancy L. Snyderman To Its Board of Directors
Lyra Therapeutics Appoints Nancy L. Snyderman To Its Board of Directors 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.